Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Mesenchymal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06641908
What this trial is testing

Anti-GD2 ADC M3554 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 65
Testing effectiveness (Phase 2)Study completedNCT04095208
What this trial is testing

Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study

Who this might be right for
Soft Tissue Sarcoma AdultAdvanced Cancer
Institut Bergonié 68
Testing effectiveness (Phase 2)Looking for participantsNCT06721689
What this trial is testing

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Who this might be right for
Refractory Solid TumorsRelapsed Solid TumorsRelapsed Neuroblastoma+3 more
Theodore Laetsch 59
Large-scale testing (Phase 3)Study completedNCT00753688
What this trial is testing

Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy

Who this might be right for
Sarcoma, Soft Tissue
GlaxoSmithKline 369
Not applicableStudy completedNCT06396962
What this trial is testing

Survival and Prognostic Factors of Primary Retroperitoneal Sarcomas After Surgery: a Single-center Experience

Who this might be right for
Primary Retroperitoneal Sarcoma
Northern Jiangsu People's Hospital 110
Testing effectiveness (Phase 2)UnknownNCT03163381
What this trial is testing

Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.

Who this might be right for
Osteosarcoma, Advanced
Henan Cancer Hospital 40
Not applicableLooking for participantsNCT07148193
What this trial is testing

Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)

Who this might be right for
SarcomaSurvivorshipQuality of Life (QOL)+1 more
Technische Universität Dresden 1,600
Not applicableWithdrawnNCT01795430
What this trial is testing

Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma

Who this might be right for
Adult Supratentorial Primitive Neuroectodermal Tumor (PNET)Ewing Sarcoma of BoneExtraosseous Ewing Sarcoma+4 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT02888665
What this trial is testing

Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Sarcoma
Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT07193550
What this trial is testing

Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)

Who this might be right for
Bone Sarcomas
M.D. Anderson Cancer Center 70
Not applicableNot Yet RecruitingNCT06029478
What this trial is testing

Understanding Engagement Trends in Chondrosarcoma Clinical Trials

Who this might be right for
Chondrosarcoma
Power Life Sciences Inc. 500
Not applicableWithdrawnNCT03868475
What this trial is testing

Comparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast Lesions

Who this might be right for
Breast FibroadenomaAtypical Ductal HyperplasiaAtypical Lobular Hyperplasia+7 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Testing effectiveness (Phase 2)Study completedNCT02008877
What this trial is testing

SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)

Who this might be right for
Malignant Peripheral Nerve Sheath Tumors (MPNST)Sarcoma
Sarcoma Alliance for Research through Collaboration 20
Testing effectiveness (Phase 2)Looking for participantsNCT05135975
What this trial is testing

Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Who this might be right for
NeuroblastomaSarcoma
Nationwide Children's Hospital 86
Not applicableStudy completedNCT04394728
What this trial is testing

Pharmacometabolomic of Trabectedin in Soft Tissue Patients

Who this might be right for
Sarcoma
Centro di Riferimento Oncologico - Aviano 44
Large-scale testing (Phase 3)Looking for participantsNCT04307277
What this trial is testing

Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Institut Claudius Regaud 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT05286801
What this trial is testing

Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors

Who this might be right for
Atypical Teratoid/Rhabdoid TumorEpithelioid SarcomaKidney Medullary Carcinoma+15 more
National Cancer Institute (NCI) 86
Not applicableEnded earlyNCT03886181
What this trial is testing

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 2
Testing effectiveness (Phase 2)Study completedNCT02768207
What this trial is testing

Detect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced Melanoma

Who this might be right for
Metastatic Melanoma
Hoffmann-La Roche 40
Early research (Phase 1)Study completedNCT00276536
What this trial is testing

Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma

Who this might be right for
Breast CancerKidney CancerLymphoma+4 more
The Cleveland Clinic 35
Next Page